President Biden is taking on the pharmaceutical industry by allowing Medicare to negotiate the price of some prescription drugs. The whole thing started last year with the passing of the Affordable Care Act. Medicare is the federal health insurance program for older and disabled people and the new provisions allowing it to negotiate drug prices... Continue Reading →
Buzzard Pharmaceuticals
Is it just me, or does Martin Shkreli, the hedge fund guy who bought the rights to a critical drug and increased the price 5000%, look like a potential super villain? You know the type in movies. He's a wormy protege of a father or a mentor that just wont give his special brand of... Continue Reading →